Skip to main content

February 2013

 

 

academics

 

Clinical research courses

NOVEL DRUG DELIVERY SYSTEM

About Authors:
Aruna Rastogi
Roorkee College of Pharmacy and UTU
Patanjali Ayurved Ltd, Sr. Chemist
arunarastogi10@gmail.com

1.   INTRODUCTION
1.1 NOVEL DRUG DELIVERY SYSTEM:
The method by which a drug is delivered can have a significant effect on its efficacy. Some drugs have an optimum concentration range within which maximum benefit is derived, and concentrations above or below this range can be toxic or produce no therapeutic benefit at all. On the other hand, the very slow progress in the efficacy of the treatment of severe diseases, has suggested a growing need for a multidisciplinary approach to the delivery of therapeutics to targets in tissues. From this, new ideas on controlling the pharmacokinetics, pharmacodynamics, non-specific toxicity, immunogenicity, biorecognition, and efficacy of drugs were generated. These new strategies, often called drug delivery systems (DDS), are based on interdisciplinary approaches that combine polymer science, pharmaceutics, bioconjugate chemistry, and molecular biology.

FORMULATION AND EVALUATION OF SR RELEASE MATRIX TABLETS OF DICLOFENAC SODIUM BY USING CHITOSAN AS A NATURAL POLYMER

About Authors:
Garje V.A1, Nagargoje S.S1, Phanse V.R1, Kshirsagar R.R1
1Dept.of Pharmaceutics. S.V.N.H.T’S College Of B.Pharmacy Rahuri Factory,
Rahuri.413706 MS,India.
*vishnugarje02@gmail.com

MNC client of Formula HRC invite M.Pharm for post of Executive /Sr.Executive-Quality Assurance (QMS)- 4 Posts

MNC client of Formula HR Consulting

Post: Executive /Sr.Executive-Quality Assurance(QMS)- 4 No's

Application are invited from Principal Investigator-Protein Biochemistry in Translational Health Science and Technology Institute

Work as Manager, Medical Writing Services in Parexel

PAREXEL has supported the Bio-Tech and Pharmaceutical industries in helping the development of new drugs and treatments on a global basis. As a leading global biopharmaceutical service provider, they supply knowledge-based contract research, medical communications and consulting services across a broad range of therapeutic areas to the worldwide pharmaceutical, biotechnology and medical device industries.

I.T.S. Paramedical Pharmacy College invites for AICTE Sponsored seminar on 5th & 6th April 2013 Pharmacovigilance: Regulators, Presepective & Prospects for Risk Management

I.T.S - The Education Group - established in 1995 under the aegis of Durga Charitable Society, is one of the most reputed education groups in the field of Pharmacy, Dentistry, Engineering, Management, Information Technology, Physiotherapy and Biotechnology. I.T.S has shown incessant growth ever since. The Group has 4 campuses, 8 Institutions and 2D courses. The quality of education is incontrovertibly laudable.

Job as Deputy General Manager– Procurement (Supply Chain Management) in Leading MNC client of Formula HR Consulting

Leading MNC client of Formula HR Consulting

Post: Deputy General Manager– Procurement(Supply Chain Management) - 1 post

REVIEW ON STEM CELL THERAPY FOR DIABETES

About Author:
Kambham Venkateswarlu
Final Year Graduate Student
Sri Lakshmi Narasimha College of Pharmacy,
Palluru, Chittoor-517132, Andhra Pradesh, India.
k.v.reddy9441701016@gmail.com

ABSTRACT:
It is the branch of medicine that involves introducing new cells into a diseased tissue to trigger the body’s ability to heal itself.
Cell therapy includes stem cell therapy, which means harvesting, transplantating or implanting stem cells in order to make healing mechanisms available in the diseased or damaged tissue itself. These stem cells may be harvested from the body of the mature adult from specialized sites where it is available such as the marrow of large bones or they may be preserved stem cells, harvested from the Umbilical cord blood or cord tissue at the time of that person’s birth.
They may also be from another donor. If the donor of the stem cells is the same as the patient in whom it is transplanted, it is called autologous cell therapy. If the donor is a different person, it is called allogenic stem cell therapy.

Require M.Pharm for Senior Executive/Manager-Regulatory Affairs - 2 posts

Formula HR consulting, Reputed pharmaceutical company

Post: Senior Executive/Manager-Regulatory Affairs- 2 No.'s

Vacancy for B.Pharm, B.Sc, MBA at Group Product Manager ( Cardio- diabetic) @ Nextus Solution

Our Client is a fully-integrated Indian pharmaceutical company manufacturing over 350 formulations and 80 APIs for various therapeutic segments.
Our Client is one of the world's largest manufacturers and suppliers of over a dozen APIs. These are produced right from the basic stage at manufacturing facilities endorsed by the world's most discerning drug regulatory authorities like US-FDA, UK-MHRA, EDQM-Europe, WHO-Geneva and many more.